Search

Your search keyword '"Carme Talarn"' showing total 3 results
Start Over Author "Carme Talarn" Journal bone marrow transplantation
3 results on '"Carme Talarn"'

1. Post thawing viable CD34+ Cells dose is a better predictor of clinical outcome in lymphoma patients undergoing autologous stem cell transplantation

Author

Jesus Fernandez-Sojo, Joan Cid, Carmen Azqueta, Elena Valdivia, Lluis Martorell, Margarita Codinach, Julia Marsal, Alberto Mussetti, Albert Esquirol, Maria Trabazo, Maria Isabel Benitez, Christelle Ferra, Maria Laura Fox, Mónica Linares, Eva Alonso, Enric García-Rey, Nadia García-Muñoz, Laura Medina, Nerea Castillo-Flores, Ferran Vall-Llovera, Antoni Garcia, Asuncion Pinacho, Carme Talarn, Jose Garcia Arroba, Rosa Coll, Mireia Santos, Oliver Valero, Enric Carreras, Miquel Lozano, and Sergio Querol

Subjects
Peripheral Blood Stem Cell Transplantation, Transplantation, Lymphoma, Hematopoietic Stem Cell Transplantation, Humans, Antigens, CD34, Hematology, Transplantation, Autologous
Published
2022
Full Text
View/download PDF

2. A real-life overview of a hematopoietic cell transplant program throughout a four-year period, including prospective registry, exclusion causes and final donor selection

Author

Clara Maluquer, M Isabel González-Medina, S Ortega, Cristina Baca, G Bustamante, Rocío Parody, Eva Domingo-Domenech, E Cabezudo, Enric Carreras, V Clapés, Mar Sánchez-Salmerón, Concepción Boqué, A C Oliveira, S. Verdesoto, H Pomares, Montserrat Arnan, Beatriz Patiño, Marta Peña, Santiago Mercadal, Alberto Mussetti, I Sánchez-Ortega, L Escoda, Nadia García, Carme Talarn, C Fusté, Anna Sureda, Juliana Villa, Itziar Carro, and Eva González-Barca

Subjects
Transplantation, medicine.medical_specialty, Myeloid, Transplantation Conditioning, Hematopoietic cell, Donor selection, business.industry, Hematopoietic Stem Cell Transplantation, Hematology, Human leukocyte antigen, Disease, Transplantation, Autologous, Donor Selection, Basal (phylogenetics), medicine.anatomical_structure, Internal medicine, Epidemiology, medicine, Humans, Registries, Sibling, business
Abstract

Traceability of patients who are candidates for Hematopoietic cell transplant (HCT) is crucial to ensure HCT program quality. Continuous knowledge of both a detailed registry from a HCT program and final exclusion causes can contribute to promoting a real-life vision and optimizing patient and donor selection. We analyzed epidemiological data reported in a 4 year-monocentric prospective registry, which included all patients presented as candidates for autologous (Auto) and/or allogeneic (Allo) HCT. A total of 543 patients were considered for HCT: 252 (42.4%) for Allo and 291 (57.6%) for Auto. A total of 98 (38.9%) patients were excluded from AlloHCT due to basal disease progression more commonly (18.2%). Seventy-six (30.2%) patients had an HLA identical sibling, whereas 147 (58.3%) patients had only Haplo. UD research was performed in 106 (42%) cases, significantly more often in myeloid than lymphoid malignancies (57% vs 28.7%, p

Published
2021

3. G-CSF increases the number of peripheral blood dendritic cells CD16+ and modifies the expression of the costimulatory molecule CD86+

Author

M Aymerich, Carme Talarn, Concepción Herrera, José Antonio Pérez-Simón, J Pétriz, Montserrat Batlle, Francesc Fernández-Avilés, Anna Gaya, Rodrigo Martino, Emili Montserrat, Alvaro Urbano-Ispizua, Jordi Sierra, and Pedro Marín

Subjects
medicine.medical_specialty, Myeloid, chemical and pharmacologic phenomena, Granulocyte, Lymphocyte Activation, Immunophenotyping, Blood cell, Antigens, CD, Internal medicine, Granulocyte Colony-Stimulating Factor, medicine, Humans, Transplantation, Homologous, Bone Marrow Transplantation, CD86, Transplantation, Hematology, business.industry, Receptors, IgG, Antibodies, Monoclonal, hemic and immune systems, Dendritic cell, Dendritic Cells, Lymphocyte Subsets, Tissue Donors, Granulocyte colony-stimulating factor, Gene Expression Regulation, Neoplastic, medicine.anatomical_structure, Immunology, B7-2 Antigen, business
Abstract

Dendritic cells (DC) play a key role in initiating immune reactions after allogeneic stem cell transplantation. The two main peripheral blood DC populations are myeloid (DC1) and lymphoplasmacytoid (DC2). A new subset of myeloid DC, expressing CD16, has been identified. We analyzed the number and CD86 expression of DC subsets in peripheral blood of 18 healthy donors, before and after granulocyte colony-stimulating factor (G-CSF) and in the inoculum of allogeneic peripheral blood transplants (allo-PBT; n=100) and allogeneic bone marrow transplants (allo-BMT; n=22). Granulocyte colony-stimulating factor administration increased the median number of DC1 (P=0.0007), of DC2 (P

Published
2006

Catalog

Books, media, physical & digital resources
See catalog results